ArticlemBio2022
Comparative Genomics of Bacteroides fragilis Group Isolates Reveals Species-Dependent Resistance Mechanisms and Validates Clinical Tools for Resistance Prediction.
Article in mBio, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 43 citations in OpenAlex.
- Diverse Genomic Mechanisms ofAntibiotics (Basel, Switzerland) · 2026Article
- Comparative genomic analysis ofMicrobiology spectrum · 2026Article
- Article
- Gut Microbiota and Dopamine: Producers, Consumers, Enzymatic Mechanisms, and In Vivo Insights.Bioengineering (Basel, Switzerland) · 2025Review
- Gene regulation inMicrobiology and molecular biology reviews : MMBR · 2025Review
- Antimicrobial resistance is widespread among intestinal and extra-intestinalInfection and immunity · 2025Article
- The Ambivalent Nature ofToxins · 2025Review
- The Emergence ofMicroorganisms · 2025Review
- Clinical Outcomes and Molecular Characteristics ofAnnals of laboratory medicine · 2025Article
- Prophages inHeliyon · 2025Article
- Megaprosthesis Infection byClinical case reports · 2025Article
- Article
- On-Site Inactivation for Disinfection of Antibiotic-Resistant Bacteria in Hospital Effluent by UV and UV-LED.Antibiotics (Basel, Switzerland) · 2024Article
- Pangenome comparison ofmSystems · 2024Article
- Broad-range amplification and sequencing of theJournal of clinical microbiology · 2024Article
- PathogenicbioRxiv : the preprint server for biology · 2024Article
- Microbiological diagnosis of pleural infections: a comparative evaluation of a novel syndromic real-time PCR panel.Microbiology spectrum · 2024Article
- Longitudinal dynamics of farmer and livestock nasal and faecal microbiomes and resistomes.Nature microbiology · 2024Article
- Pangenome comparison ofbioRxiv : the preprint server for biology · 2023Article
- Roving methyltransferases generate a mosaic epigenetic landscape and influence evolution in Bacteroides fragilis group.Nature communications · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
Abstract
Bacteroides fragilis group (BFG) are the most frequently recovered anaerobic bacteria from human infections, and resistance to frontline antibiotics is emerging. In the absence of routine antimicrobial susceptibility testing (AST) for BFG in most clinical settings, we assessed the utility of clinical and modern genomics tools to determine BFG species-level identification and resistance patterns. A total of 174 BFG clinical isolates supplemented with 20 archived carbapenem-resistant B. fragilis
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.